Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
61.76
+2.27 (3.82%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Sarepta Therapeutics Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$153.50
Upside
+148.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $182 → $110 | Buy | Maintains | $182 → $110 | +78.11% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +21.44% | Apr 16, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $196 → $182 | Buy | Maintains | $196 → $182 | +194.69% | Apr 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $115 | Buy | Initiates | $115 | +86.20% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +21.44% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $75 | Hold | Reiterates | $75 | +21.44% | Apr 4, 2025 |
| Needham | Needham | Strong Buy Maintains $202 → $183 | Strong Buy | Maintains | $202 → $183 | +196.31% | Apr 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell → Hold Upgrades $75 | Strong Sell → Hold | Upgrades | $75 | +21.44% | Apr 2, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $161 → $87 | Buy → Hold | Downgrades | $161 → $87 | +40.87% | Mar 31, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $105 → $80 | Hold | Maintains | $105 → $80 | +29.53% | Mar 20, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $163 | Buy | Reiterates | $163 | +163.92% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Sell Reiterates $75 | Strong Sell | Reiterates | $75 | +21.44% | Mar 19, 2025 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $124 → $99 | Hold | Maintains | $124 → $99 | +60.30% | Mar 19, 2025 |
| Needham | Needham | Strong Buy Reiterates $202 | Strong Buy | Reiterates | $202 | +227.07% | Mar 18, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $163 | Buy | Reiterates | $163 | +163.92% | Mar 18, 2025 |
| Scotiabank | Scotiabank | Hold Initiates $105 | Hold | Initiates | $105 | +70.01% | Mar 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.